Resources for patients2023-03-07T13:15:32+00:00

Resources for patients, families and caregivers living with hearing loss

People are at the heart of Rinri’s work. Hearing loss, and how this condition affects everyday lives are central to everything we do. To ensure that we never lose sight of this, we work closely with patients throughout the development of our cell therapy. We also work with charities, hospitals, academic institutions and industry bodies, inside and outside the hearing loss space, to guide our development and raise awareness of hearing health.

What is Rinri’s therapeutic approach to treating hearing loss?2023-02-06T16:56:36+00:00

Hearing in humans is managed by a specialised organ called the cochlea. The cochlea contains specialised sensory cells that detect sound and transmit this to the brain. Rinri is developing the world’s first regenerative cell therapies capable of repairing damaged sensory cells in the cochlea.

What is Rincell-1 designed to treat?2023-02-06T16:56:25+00:00

Rinri’s first product, Rincell-1, is designed to regenerate the auditory nerves in the inner ears of patients with hearing loss caused by damage to these cells.

Our research clearly demonstrates that Rincell-1 can survive, engraft, mature and re-establish neural connections to auditory hair cells and wider auditory neural architecture. In models of auditory neuron-related hearing loss, these cells result in a reversal of hearing loss and a 40% improvement in the hearing threshold.

How can I learn if I am eligible for a clinical trial?2023-02-06T16:55:58+00:00

For information regarding ongoing clinical trials, and evaluating our drug candidates, please refer to Be Part of Research ( and follow up with your healthcare provider. You may search by disease, location of clinical trials, or by the name of the company sponsoring the clinical trials. Additionally, you can find information on clinical trials on the RNID website.

You may also email

When will clinical trials of Rincell-1 be available in other countries?2023-02-06T16:55:44+00:00

Rinri is currently focused on developing Rincell-1 and its application in the UK.

When will Rincell-1 become commercially available?2023-02-06T16:55:28+00:00

To stay informed on the status of our clinical studies, please reference our latest press releases and the Investors & Media section of our website.

Will Rincell-1 be used as a potential treatment for other conditions?2023-02-06T16:55:13+00:00

Rincell-1 is being developed to restore hearing in patients with acquired sensorineural hearing loss, specifically auditory neuron-related hearing loss. As trials progress, it may have further applications.

Resources for patients, families and caregivers living with hearing loss
Go to Top